CTRI/2018/01/011184
Not yet recruiting
Phase 2
A clinical study to evaluate the efficacy and safety of ayurvedic formulations (Capsule and syrup Shwasi) in the management of Tamak Shwas w.s.r. to Bronchial Asthma
Shree Dhanwantri Herbals Amritsar0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients with Episodic Bronchial Asthma
- Sponsor
- Shree Dhanwantri Herbals Amritsar
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients willing for trial.
- •2\. Age between 20 \-60 years of either sex.
- •3\. Patients presenting with clinical features of Tamak Shwas/Bronchial Asthma with impaired PFT.
Exclusion Criteria
- •1\. Patients not willing for the trial or not ready to give informed consent.
- •2\. Patients of age \< 20 and above 60 years
- •3\. Patients with Uncontrolled Hypertension and
- •Diabetes mellitus with complications.
- •4\. Patients having malignancy, chronic cardiac illness, hepatic disorders, renal disorders, tuberculosis and other comorbid diseases.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study to evaluate the advanatges and safety of long term CurQfen consumption in dementia patientsHealth Condition 1: null- DementiaCTRI/2018/03/012410Akay Flavours and Aromatics Private Limited48
Completed
Not Applicable
A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive prostate cancer who have previously recieved docetaxelJPRN-UMIN000012521Department of Urology, Keio University School of Medicine20
Completed
Phase 4
Evaluate the safety and efficacy of test product in improvement of skin .CTRI/2023/02/050063ZeusHygia Life sciences Pvt Ltd80
Not yet recruiting
Not Applicable
A clinical study to evaluate the efficacy and safety of MegaCarti® as a treatment for cartilage regeneration in patients with knee joint cartilage injury : Multicenter, microfracture control, randomization, superiority clinical trialInjury, poisoning and certain other consequences of external causesKCT0008226&C BIO64
Recruiting
Phase 2
Clinical study to evaluate the Efficacy and safety of nutraceutical formulation in neurodegenerative diseases linked to cognitive impairmentHealth Condition 1: G300- Alzheimers disease with early onsetCTRI/2022/03/040964CSIR